FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
[2008/06/17] [Food and Drug Administration (FDA)]
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
|
Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
[2006/08/22] [Embria (TM) Health Sciences]
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
|
Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
[2006/06/29] [Ribbon Nutrition]
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
|
Sabinsa Invites Noted Researcher to Discuss Role of Turmeric-Derived Curcuminoids in Treatment of Cancer at SupplySide West
[2005/10/26] [Sabinsa Corporation]
Company will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo.
|
Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
[2005/10/03] [Indena]
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
|
FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
[2005/07/01] [Food and Drug Administration (FDA)]
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
|
Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
[2004/12/16] [Bastyr University]
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
|
eWorldMedia, Inc. Reaches Agreement in Principle with Natura, Inc. for International Marketing Rights to Cellular Health and Nutrition Line
[2004/12/03] [eWorldMedia, Inc.]
Company has reached an "Agreement in Principle" with Natura, Inc. to market Natura's product line of cellular health and nutrition products through eWorldMedia's international base of distributors.
|
International Cancer Conference Explores New Weapons in the Fight Against Colorectal Cancer
[2004/11/02]
Special symposium held, focused on “IP6 and Cell Signaling in Fighting Cancer: From Laboratory to Clinic.”
|
Complementary Prostate Cancer Therapies To Be Discussed at Calif. State Oriental Medical Assoc. Expo
[2004/08/09]
Integrative approaches to counteracting the side-effects of cancer through dietary supplements, herbal formulas and acupuncture will be presented by Isaac Eliaz, M.D., M.S.C., L.Ac.
|
Unigen Pharmaceuticals Partners with the National Cancer Institute and the Ford Cancer Center to Discover Anti-Solid Tumor Pharmaceutical Drugs
[2004/02/20] [Unigen Pharmaceuticals, Inc.]
|